Tissue immune profiles supporting response to mesenchymal stromal cell therapy in acute graft-versus-host disease—a gut feeling

por Gavin, Caroline, Boberg, Erik, Von Bahr, Lena, Bottai, Matteo, Andrén, Anton Törnqvist, Wernerson, Annika, Davies, Lindsay C., Sugars, Rachael V., Le Blanc, Katarina
Publicado 2019

Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study

por Boberg, Erik, von Bahr, Lena, Afram, Gabriel, Lindström, Carina, Ljungman, Per, Heldring, Nina, Petzelbauer, Peter, Garming Legert, Karin, Kadri, Nadir, Le Blanc, Katarina
Publicado 2020

Mesenchymal Stromal Cells Engage Complement and Complement Receptor Bearing Innate Effector Cells to Modulate Immune Responses

por Moll, Guido, Jitschin, Regina, von Bahr, Lena, Rasmusson-Duprez, Ida, Sundberg, Berit, Lönnies, Lena, Elgue, Graciela, Nilsson-Ekdahl, Kristina, Mougiakakos, Dimitrios, Lambris, John D., Ringdén, Olle, Le Blanc, Katarina, Nilsson, Bo
Publicado 2011

Do ABO Blood Group Antigens Hamper the Therapeutic Efficacy of Mesenchymal Stromal Cells?

por Moll, Guido, Hult, Annika, von Bahr, Lena, Alm, Jessica J., Heldring, Nina, Hamad, Osama A., Stenbeck-Funke, Lillemor, Larsson, Stella, Teramura, Yuji, Roelofs, Helene, Nilsson, Bo, Fibbe, Willem E., Olsson, Martin L., Le Blanc, Katarina
Publicado 2014